DeDora Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$33.4K Buy
+1,170
New +$31.1K 0.01% 210
2023
Q2
– Sell
-12,068
Closed -$492K – 105
2023
Q1
$492K Sell
12,068
-502
-4% -$21.7K 0.21% 77
2022
Q4
$644K Buy
12,570
+6,682
+113% +$320K 0.31% 69
2022
Q3
$258K Buy
5,888
+549
+10% +$26.7K 0.13% 90
2022
Q2
$280K Buy
5,339
+301
+6% +$15.3K 0.14% 85
2022
Q1
$261K Sell
5,038
-53
-1% -$2.75K 0.11% 86
2021
Q4
$301K Sell
5,091
-16
-0.3% -$793 0.17% 46
2021
Q3
$220K Sell
5,107
-348
-6% -$15.4K 0.1% 93
2021
Q2
$214K Buy
+5,455
New +$212K 0.09% 93
2020
Q4
– Sell
-11,314
Closed -$394K – 93
2020
Q3
$394K Sell
11,314
-1,882
-14% -$66K 0.22% 73
2020
Q2
$409K Buy
13,196
+366
+3% +$12.4K 0.25% 71
2020
Q1
$397K Sell
12,830
-149
-1% -$5.08K 0.3% 64
2019
Q4
$482K Sell
12,979
-307
-2% -$10.9K 0.29% 64
2019
Q3
$453K Buy
13,286
+626
+5% +$22.8K 0.31% 59
2019
Q2
$520K Buy
12,660
+324
+3% +$12.9K 0.37% 56
2019
Q1
$497K Buy
12,336
+3,570
+41% +$143K 0.37% 54
2018
Q4
$363K Sell
8,766
-532
-6% -$22.1K 0.32% 58
2018
Q3
$389K Sell
9,298
-1,141
-11% -$43.9K 0.29% 58
2018
Q2
$359K Sell
10,439
-3,301
-24% -$113K 0.28% 69
2018
Q1
$463K Sell
13,740
-310
-2% -$10.7K 0.38% 53
2017
Q4
$483K Buy
+14,050
New +$479K 0.4% 49

Other funds holding PFE

DeDora Capital's PFE Position: Q3 2026 in Review

DeDora Capital opened a new position in Pfizer (PFE) in Q3 2026: 1,170 shares worth $33.4K. The stake represents 0.01% of the portfolio and ranks #210 among its holdings. This is a return to the name: DeDora Capital previously reported a position in PFE as recently as Q1 2023.

DeDora Capital first reported a position in PFE in Q4 2017 and has held it in 21 quarters since. The position peaked at $644K in Q4 2022. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • DeDora Capital held 1,170 shares of Pfizer worth $33.4K as of Q3 2026.
  • Pfizer was a new DeDora Capital position in Q3 2026.
  • Pfizer made up 0.01% of DeDora Capital's portfolio in Q3 2026, its #210 holding.
  • DeDora Capital first reported a position in Pfizer in Q4 2017 and has held it in 21 quarters since.
  • DeDora Capital's Pfizer position peaked at $644K in Q4 2022.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on DeDora Capital's 13F filing for Q3 2026, filed 26 Oct 2026.